Exelon
rivastigmine
- Strength
- 9.5 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Novartis Pharmaceuticals Corporation
Rivastigmine
Listed by Zydus Lifesciences Limited
- Strength
- 9.5 mg/24h
- Form
- Patch, Extended Release
- Route
- Transdermal
- Class
- Cholinesterase Inhibitor
What it contains
- Rivastigmine 9.5 mg/24h
FDA record
| Dosage form | Patch, Extended Release |
|---|---|
| Route | Transdermal |
| Drug class | Cholinesterase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 70771-1950 |
| FDA application | ANDA206318 |
| RxNorm concept | 725021 |
| Package sizes listed | 1 |
| Marketed since | March 2019 |
Other products containing Rivastigmine
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Exelon
rivastigmine
- Strength
- 13.3 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Sandoz Inc
Exelon
rivastigmine
- Strength
- 13.3 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Novartis Pharmaceuticals Corporation
Exelon
rivastigmine
- Strength
- 4.6 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Novartis Pharmaceuticals Corporation
Exelon
rivastigmine
- Strength
- 4.6 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Sandoz Inc
Exelon
rivastigmine
- Strength
- 9.5 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Sandoz Inc
Rivastigmine
- Strength
- 13.3 mg/24h
- Form
- Patch, Extended Release
- Class
- Cholinesterase Inhibitor
Sandoz Inc
Rivastigmine
- Strength
- 9.5 mg/24h
- Form
- Patch
- Class
- Cholinesterase Inhibitor
Amneal Pharmaceuticals LLC
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.